Showing results (21-30 of 217) with videos related to

Sort By:
Pageof 22
Frontiers in Oncology|November 16, 2020
Differentiation of COVID-19 Pneumonitis and ICI Induced PneumonitisDaphne W Dumoulin, Hester A Gietema, Marthe S Paats, et al.
Translational Lung Cancer Research|August 25, 2021
How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative reviewJordi Remon, Jessica Menis, Antonin Levy, et al.
Journal of Thoracic Disease|June 29, 2018
Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patientsJordi Remon, Laura Mezquita, Jesús Corral, et al.
Lung Cancer (Amsterdam, Netherlands)|November 26, 2002
DNA repair and cisplatin resistance in non-small-cell lung cancerRafael Rosell, Reginald V N Lord, Miquel Taron, et al.
Current Opinion in Pharmacology|June 13, 2006
Predicting the outcome of chemotherapy for lung cancerRafael Rosell, Fabiana Cecere, Mariacarmela Santarpia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathwayRafael Rosell, Miquel Taron, Noemi Reguart, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2026
Updates in Small Cell Lung Cancer Treatment: No Longer Too Small to Ignore-A Review of Recent Therapeutic AdvancesYajur Arya, Patrick Dyer, Fiona Hegi-Johnson, et al.
Nature Reviews. Disease Primers|August 21, 2025
Lung metastasesLodovica Zullo, Dimitris Filippiadis, Lizza E L Hendriks, et al.
Future Oncology (London, England)|March 25, 2006
The role of Wnt signaling in cancer and stem cellsNoemi Reguart, Biao He, Miquel Taron, et al.
European Journal of Cancer (Oxford, England : 1990)|March 17, 2023
Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterationsFrancesco Cortiula, Dirk De Ruysscher, Michelle Steens, et al.
Pageof 22